Topical virucidal composition for treatment of mucocutaneous tis

Details Topical virucidal composition for treatment of mucocutaneous tis Topical virucidal composition for treatment of mucocutaneous tis

1991-07-16

1993-01-26

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Topical body preparation containing solid synthetic organic...

Anti-infective

424405, 514887, 514717, A01N 3114, A61K 31075

Patent

active

051821044

ABSTRACT:
This invention pertains to a topically applied composition with a virucidal impact on mucocutaneous tissue. Ingredients essential to the efficacy of the formulated combination include a polyethylene glycol polymer known as Nonoxynol-9("N-9")in admixture with selected fat soluble vitamins A, D and E in the form of vegetable oil (and) retynyl palmitate (and) ergocalciferol together with tocopherol acetate. The invention is directed particularly to inactivation of herpes virus and human papilloma virus as manifested in cold sores, lesions, fever blisters, canker sores and warts. The N-9 contains viral activity while the vitamins effect restoration and strengthening of the damaged tissue cells.

REFERENCES:
patent: 4201235 (1980-05-01), Ciavatta
patent: 4670471 (1987-06-01), Clark
patent: 4883659 (1989-11-01), Goodman et al.
Koop, C. Everett, M.D., ScD, Surgeon General, Oct. 16, 1987, 258JAMA2111.

Affiliated with

Also associated with

Rating

Topical virucidal composition for treatment of mucocutaneous tis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical virucidal composition for treatment of mucocutaneous tis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical virucidal composition for treatment of mucocutaneous tis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1411715